New Research Poster 3 (open)
New Research Posters Session 3

Thursday, October 24, 2013: 1:00 PM-3:30 PM
 
3.1
Meta-Analysis of Suicide-Related Behavior or Ideation in Child, Adolescent, and Adult Patients Treated with Atomoxetine
Mark E. Bangs, MD Eli Lilly and Company, Indianapolis, IN
Linda Wietecha, BSN, MS Eli Lilly and Company, Indianapolis, IN
Shufang Wang, PhD Eli Lilly and Company, Indianapolis, IN
Andrew Buchanan, BS Eli Lilly and Company, Indianapolis, IN
Douglas K. Kelsey, MD Eli Lilly and Company, Indianapolis, IN
 
3.2
Clinical Correlates of Ferritin Level and ADHD in Children: Should We Check Ferritin Level?
Jyoti Bhagia, MD Mayo Clinic, Rochester, MN
Kumi Yuki, MD Mayo Clinic, Rochester, MN
Jyothsna Giri, MD Mayo Clinic, Rochester, MN
Peter S. Jensen, MD The REACH Institute, New York, NY
 
3.3
Preferences for Non-Stimulant ADHD Treatment Characteristics Among Children/Adolescents with ADHD and Their Caregivers
Daniel F. Connor, MD University of Connecticut Medical School, Farmington, CT
Frank A. Lopez, MD Children’s Development Center, Winter Park, FL
Emuella Flood, BA Oxford Outcomes, an ICON plc company, Bethesda, MD
Vanja Sikirica, PharmD, MPH Shire Development, LLC, Wayne, PA
Kavita Gajria, BS, MS Shire Development, LLC, Wayne, PA
Jessica Grinspan, BS Oxford Outcomes, an ICON plc company, Bethesda, MD
Paul Hodgkins, MSC, PhD Shire Pharmaceuticals, Inc., Wayne, PA
M. Haim Erder, PhD Shire Development, LLC, Wayne, PA
 
3.4
Moderators of Comorbidity Between Childhood Asthma and ADHD
Leigh C. Gayle, BS University of Virginia Health System, Charlottesville, VA
Vishal Madaan, MD, FAAP University of Virginia Health System, Charlottesville, VA
 
3.5
Receipt of Psychotherapy Among Children Taking ADHD Medication: A National Study
Walid F Gellad, MD, MPH RAND Health, Pittsburgh, PA
Teague Ruder, MA RAND Health, Pittsburgh, PA
Ateev Mehrotra, MD, MPH RAND Health, Pittsburgh, PA
Rochelle Henderson, PhD Express Scripts, St. Louis, MO
Sharon G. Frazee, MPH, PhD Express Scripts, St. Louis, MO
Bradley D. Stein, MD, PhD RAND Health, Pittsburgh, PA
Julie M Donohue, PhD University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA
 
3.6
Prevalence of ADHD in Pediatric Epilepsy Patients
Michael S. Hammer, MD Children's Hospital of Wisconsin, Glenview, IL
 
3.7
Economic Burden of ADHD
Juliana Setyawan, MS, PharmD Shire Pharmaceuticals, Inc., Wayne, PA
Jennifer Kahle, PhD BPS International, San Diego, CA
Hoa Le, PhD University of Groningen, Groningen Netherlands
Paul Hodgkins, MSC, PhD Shire Pharmaceuticals, Inc., Wayne, PA
Maarten Postma, PhD University of Groningen, Groningen Netherlands
Peter Neumann, DSc Tufts Medical Center, Boston, MA
Vanja Sikirica, PharmD, MPH Shire Development, LLC, Wayne, PA
M. Haim Erder, PhD Shire Development, LLC, Wayne, PA
Michael Cangelosi, MA, MPH Tufts Medical Center, Boston, MA
Jalpa A. Doshi, PhD University of Pennsylvania, Philadelphia, PA
 
3.8
Anxiety Among Children in the United States, 2011-2012
Rebecca H. Bitsko, PhD Centers for Disease Control and Prevention, Atlanta, GA
Joseph Holbrook, PhD Centers for Disease Control and Prevention, Atlanta, GA
Reem Ghandour, PhD The Health Resources and Services Administration, Rockville, MD
Susanna Visser, MS Centers for Disease Control and Prevention, Atlanta, GA
Ruth Perou, PhD Centers for Disease Control and Prevention, Atlanta, GA
Stephen Blumberg, PhD Centers for Disease Control and Prevention, Hyattsville, MD
 
3.9
Prevalence and Impact of Tourette's Disorder Among Children in the United States, 2011-2012
Rebecca H. Bitsko, PhD Centers for Disease Control and Prevention, Atlanta, GA
Joseph Holbrook, PhD Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, MS Centers for Disease Control and Prevention, Atlanta, GA
Jonathan W. Mink, MD, PhD University of Rochester Medical Center, Rochester, NY
Samuel Zinner, MD Seattle Children's Hospital, Seattle, WA
Reem Ghandour, PhD The Health Resources and Services Administration, Rockville, MD
Stephen Blumberg, PhD Centers for Disease Control and Prevention, Hyattsville, MD
 
3.10
ADHD Treatment Patterns in a Community-Based Epidemiological Sample of Boys and Girls Over Time
Joseph Holbrook, PhD Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, MS Centers for Disease Control and Prevention, Atlanta, GA
Melissa Danielson, MSPH Centers for Disease Control and Prevention, Atlanta, GA
Steven P. Cuffe, MD University of Florida College of Medicine, Jacksonville, Jacksonville, FL
Robert E. McKeown, PhD Greenville Health System, Pisgah Forest USA
Mark L. Wolraich, MD University of Oklahoma Health Sciences Center, Oklahoma City, OK
 
3.11
Prevalence and Co-Occurrence of Parent-Reported Disruptive Behavioral Disorders Among Children in the United States
Susanna Visser, MS Centers for Disease Control and Prevention, Atlanta, GA
Melissa Danielson, MSPH Centers for Disease Control and Prevention, Atlanta, GA
Joseph Holbrook, PhD Centers for Disease Control and Prevention, Atlanta, GA
Rebecca H. Bitsko, PhD Centers for Disease Control and Prevention, Atlanta, GA
 
3.12
Demographic Patterns in ADHD Subtypes Among a Community-Based Sample of Children Across Two States
Susanna Visser, MS Centers for Disease Control and Prevention, Atlanta, GA
Joseph Holbrook, PhD Centers for Disease Control and Prevention, Atlanta, GA
Melissa Danielson, MSPH Centers for Disease Control and Prevention, Atlanta, GA
Robert E. McKeown, PhD Greenville Health System, Pisgah Forest USA
Steven P. Cuffe, MD University of Florida College of Medicine, Jacksonville, Jacksonville, FL
Mark L. Wolraich, MD University of Oklahoma Health Sciences Center, Oklahoma City, OK
 
3.15
Gender and Childhood Emotional Disorders
Rikke Wesselhoeft, MD Mental Health Services in the Region of Southern Denmark, Odense Denmark
Carsten B. Pedersen Aarhus University, Business and Social Sciences, Aarhus Denmark
Ole Mors, MD Aarhus University Hospital, Risskov Denmark
Preben B. Mortensen, MD Aarhus University, Business and Social Sciences, Aarhus Denmark
Niels Bilenberg, MD Mental Health Services in the Region of Southern Denmark, Odense Denmark
 
3.17
Prevalence and Correlates of Problematic Internet Experiences and Computer-Overuse: A Two-Year Longitudinal Study in Korean Schoolchildren
Su-Jin Yang, MD, PhD Gangnam Severance Hospital, Seoul South Korea
 
3.19
Effect of Methylphenidate on Weight and Height in Korean Children and Adolescents with ADHD
Hyo-Won Kim, MD, PhD University of Ulsan College of Medicine, Asan Medical Center, Seoul South Korea
Seon-Ok Kim, MS University of Ulsan College of Medicine, Asan Medical Center, Seoul South Korea
Seunghyun Shon, MD University of Ulsan College of Medicine, Asan Medical Center, Seoul South Korea
Jung-Sun Lee, MD, PhD University of Ulsan College of Medicine, Asan Medical Center, Seoul South Korea
Jin-Ho Choi, MD, PhD Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul South Korea
 
3.20
Longitudinal Trajectories of ADHD Symptomatology in Offspring of Parents with Bipolar Disorder and Community Controls
Jae-Won Kim, MD, PhD Seoul National University College of Medicine, Seoul South Korea
Haifeng Yu, MS University of Pittsburgh School of Medicine, Pittsburgh, PA
Neal Ryan, M.D. University of Pittsburgh Medical Center, Pittsburgh, PA
David Axelson, MD University of Pittsburgh School of Medicine, Pittsburgh, PA
Kelly Monk, RN Western Psychiatric Institute & Clinic, Pittsburgh, PA
Benjamin I. Goldstein, MD, PhD Sunnybrook Health Sciences Centre, Toronto, ON
Tina R. Goldstein, PhD University of Pittsburgh Medical Center, Pittsburgh, PA
Boris Birmaher, MD Western Psychiatric Institute & Clinic, Pittsburgh, PA
 
3.21
Machine Learning Approach Using Genetic, Environmental, Neuroimaging, and Neuropsychological Markers Can Predict ADHD Diagnosis and Methylphenidate Response
Jae-Won Kim, MD, PhD Seoul National University College of Medicine, Seoul South Korea
Vinod Sharma, PhD University of Pittsburgh School of Medicine, Pittsburgh, PA
Neal Ryan, M.D. University of Pittsburgh Medical Center, Pittsburgh, PA
 
3.22
Discovering Common Functional and Structural Brain Regions of ADHD Using a Large Neuroimaging Data Set
Sunghyon Kyeong, MS National Institute for Mathematical Sciences, Daejeon South Korea
Jung Min Lee, PhD National Institute for Mathematical Sciences, Daejeon South Korea
Eunjoo Kim, MD Yonsei University Graduate School, Seoul South Korea
 
3.23
Clinical Characteristics and Neuropsychological Profiles of Children with ADHD and Their Siblings
Hyun-jeong Lee, MD Asan Medical Center Children's Hospital, Seoul South Korea
Hyo-Won Kim, MD, PhD University of Ulsan College of Medicine, Asan Medical Center, Seoul South Korea
Jangho Park, MD University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan South Korea
Kyung Mi Kang, MD, PhD I Mom Child & Adolescent Neuropsychiatric Clinic, Seoul South Korea
 
3.24
An Exploring Research to the Agreement of Symptoms Reports Between Children with ADHD and Parents
Yu Shiuan Lin, BS College of Medicine at National Taiwan University, Taipei City Taiwan
CHI Yung Shang, MD, PhD College of Medicine at National Taiwan University, Taipei City Taiwan
 
3.25
Oppositional Behaviors Mediate the Relationship Between Executive Dysfunction and Parenting Stress in Children with ADHD
Katherine M. Matheson, MD Dalhousie University, Halifax, NS
Alan McLuckie, PhD Dalhousie University, Dartmouth, NS
Melissa Jane Rowbotham, MEd Integra, Toronto, ON
David Ng University of Toronto, Toronto, ON
Michael Schwartz, PhD Private Practice, Thornhill, ON
 
3.26
Comorbid Oppositional-Defiant Disorder and Depression Predict Suicide Ideation and Attempts in Children with ADHD
Susan D. Mayes, PhD Penn State Hershey College of Medicine, Hershey, PA
Raman Baweja, MD Penn State Milton S Hershey Medical Center, Hershey, PA
Ehsan U. Syed, MD Pennsylvania Psychiatric Institute, Harrisburg, PA
Angela A. Gorman, PhD Penn State Hershey College of Medicine, Hershey, PA
Jose L. Montaner, MD Penn State Hershey College of Medicine, Hershey, PA
Lance Feldman, MD Penn State Hershey College of Medicine, Hershey, PA
Jitendra Reddy Annapareddy, MD Penn State Hershey College of Medicine, Hershey, PA
Nidhi Gupta, MD Penn State Hershey College of Medicine, Hummelstown, PA
Ademola Bello, MD Penn State Hershey College of Medicine, Hershey, PA
Farhat S. Siddiqui, MD Penn State Hershey College of Medicine, Hershey, PA
Susan L. Calhoun, PhD Penn State Hershey College of Medicine, Hershey, PA
 
3.27
A Pilot Study of Trigeminal Nerve Stimulation for ADHD
James J. McGough, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Sandra K. Loo, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Alexandra Sturm, BS UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Jennifer Cowen, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Andrew Leuchter, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Ian A. Cook, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
 
3.28
Screening for Neurodevelopmental Problems: The Effect of ADHD on Psychosocial Outcome at Age 15
Eva G.M. Noren Selinus, MD Karolinska Institute, Stockholm Sweden
Yasmina Molero, MD Karolinska Institutet, Solna Sweden
Paul Lichtenstein, PhD Karolinska Institutet, Stockholm Sweden
Tomas Larson, MD Lund University, Lund Sweden
Sebastian Lundström, MD University of Gothenburg, Göteborg Sweden
Henrik Anckarsäter, MD Lund University, Lund Sweden
Clara Hellner Gumpert, MD Karolinska Institutet, Solna Sweden
 
3.29
The Loudness Dependence of the Auditory Evoked Potential in Children with ADHD
Eun Jin Park, MD Inje University Ilsan Paik Hospital, Goyang South Korea
Bongseog Kim, MD, PhD Sanggyepaik Hospital, Seoul South Korea
Jewook Kang, MD Inje University Busan Paik Hospital, Busan South Korea
 
3.30
Do Parent Personality Traits Moderate Treatment Response in the Multimodal Treatment Study of Children with ADHD?
Guillermo Perez Algorta, PhD The Ohio State University, Columbus, OH
L. Eugene Arnold, MD Ohio State University, Sunbury, OH
Rebecca Andridge, PhD The Ohio State University, Columbus, OH
Stephen P. Hinshaw, PhD University of California, Berkeley, Berkley, CA
James M. Swanson, PhD The UC Irvine Child Development Center, Irvine, CA
Desiree W. Murray, PhD Duke University, Durham, NC
Howard B. Abikoff, PhD New York University Child Study Center, New York, NY
Lily Hechtman, MD McGill University Health Center, Montreal, QC
 
3.31
Modifiers of Parenting Stress When a Child Has ADHD
Guillermo Perez Algorta, PhD The Ohio State University, Columbus, OH
Carolyn Kragh, BS The Ohio State University, Columbus, OH
L. Eugene Arnold, MD Ohio State University, Sunbury, OH
Brooke S.G. Molina, PhD University of Pittsburgh, Pittsburgh, PA
Stephen P. Hinshaw, PhD University of California, Berkeley, Berkley, CA
 
3.32
Time-Course of Treatment-Emergent Adverse Events Following Administration of an Extended-Release Methylphenidate Oral Suspension
Adelaide S. Robb, MD Children’s National Medical Center, Washington, DC
John A. Gillespie, MD, MBA Pfizer Inc., New York, NY
Heidi W. Belden, PharmD Pfizer Inc., New York, NY
Sally A. Berry, MD, PhD Pfizer Inc., New York, NY
 
3.33
The Children's ADHD Telemental Health Treatment Study Treatment Outcomes: The Medication Strategies Used, and Effects of “Active Medication Management”
Carol M. Rockhill, MD, PhD, MPH Children's Bellevue, Bellevue, WA
William P. French, MD Seattle Children's Hospital, Seattle, WA
Lee Carlisle, MD Seattle Children's Hospital, Seattle, WA
Yuet Juhn Tse, BS Seattle Children's Research Institute, Seattle, WA
Chuan Zhou, PhD University of Washington, Seattle, WA
Ann Vander Stoep, PhD University of Washington School of Medicine and Public Health, Seattle, WA
Kathleen Myers, MD, MPH, MS Seattle Children's Hospital, Seattle, WA
 
3.34
Short Interval Cortical Inhibition and Atomoxetine Response in Children with ADHD
Floyd R. Sallee, MD, PhD University of Cincinnati, Cincinnati, OH
Tina Chen, BS University of Cincinnati College of Medicine, Cincinnati, OH
Steve Wu, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Jeffrey A. Welge, PhD University of Cincinnati, Cincinnati, OH
Donald L. Gilbert, MD, MS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
 
3.35
The Impact Of Co-Existing Problems on the Development of Social and School Competence Among Children with ADHD
Jorun Schei, MD St. Olavs Hospital Trondheim University Hospital, Trondheim Norway
Thomas Jozefiak, MD, PhD Norwegian University of Science and Technology, Trondheim Norway
Stian Lydersen, PhD Norwegian University of Science and Technology, Trondheim Norway
Torunn Novik, MD, PhD St. Olavs Hospital Trondheim University Hospital, Trondheim Norway
 
3.36
Exploring Adolescents' Perspective of Functioning in ADHD for Evaluating Treatment Outcomes
Juliana Setyawan, MS, PharmD Shire Pharmaceuticals, Inc., Wayne, PA
Asha Hareendran, PhD United BioSource Corporation, London United Kingdom
Paul Hodgkins, MSC, PhD Shire Pharmaceuticals, Inc., Wayne, PA
Robin Pokrzywinski, MHA United BioSource Corporation, Bethesda, MD
M. Haim Erder, PhD Shire Development, LLC, Wayne, PA
 
3.37
Caregiver Depressive Symptoms Predict Discrepancies Between Caregiver, Teacher, and Youth Ratings of Psychopathology in Adolescents with ADHD
Katherine Marie Shea, MD Dartmouth-Hitchcock Medical Center, Lebanon, NH
William Burleson Daviss, MD Dartmouth-Hitchcock Medical Center, Lebanon, NH
 
3.38
Evaluation of a Method That Integrates an Electroencephalographic Biomarker with a Clinician's Assessment of ADHD
Steven M. Snyder, PhD NEBA Health, LLC, Boulder, CO
Thomas Rugino, MD Children's Specialized Hospital, Toms River, NJ
Mady Hornig, MD Columbia University, New York, NY
Mark A. Stein, PhD University of Washington, Seattle, WA
 
3.39
Comparison of Symptomatic and Functional Changes in Korean Children and Adolescents with ADHD: A Multisite, Open, Labeled Study
Dong-Ho Song, MD, PhD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Eunjoo Kim, MD Yonsei University Graduate School, Seoul South Korea
Keun-Ah Cheon, M.D. Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Sun Young Kim, MD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Woo Young Lim, MD Yonsei University School of Medicine, Seoul South Korea
Eun-Young Shin, MD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
 
3.40
Oral Bioavailability/Bioequivalence of a Novel Investigational Extended-Release Oral Disintegrating Tablet Formulation of Amphetamine for ADHD
Jeffrey G. Stark, PhD Worldwide Clinical Trials, Austin, TX
Russ McMahen NEOS Therapeutics Inc., Grand Prairie, TX
Carolyn R. Sikes, PhD NEOS Therapeutics Inc., Grand Prairie, TX
Mark Tengler NEOS Therapeutics Inc., Grand Prairie, TX
 
3.41
Pharmacokinetic Study of a Novel Extended-Release Formulation of Amphetamine Oral Disintegrating Tablet in Children Ages 6-12 with ADHD
Jeffrey G. Stark, PhD Worldwide Clinical Trials, Austin, TX
Russ McMahen NEOS Therapeutics Inc., Grand Prairie, TX
Carolyn R. Sikes, PhD NEOS Therapeutics Inc., Grand Prairie, TX
Mark Tengler NEOS Therapeutics Inc., Grand Prairie, TX
 
3.42
Time to Onset and Resolution of Adverse Events and Changes in Blood Pressure and Pulse Following Atomoxetine Treatment in Adult Patients with ADHD
Himanshu P. Upadhyaya, MBBS, MS Eli Lilly and Company, Bellaire, TX
Yoko Tanaka, PhD Lilly Research Laboratories, Indianapolis, IN
Sarah Lipsius, MS inVentiv Health, Ann Arbor, MI
Angelo Camporeale, MD Lilly Research Laboratories, Indianapolis, IN
Jeannine Lane, PhD inVentiv Health, Ann Arbor, MI
Rodrigo Escobar, MD Eli Lilly and Company, Indianapolis, IN
Paula T. Trzepacz, MD Eli Lilly and Company, Indianapolis, IN
Albert John Allen, MD, PhD Eli Lilly and Company, Indianapolis, IN
 
3.43
ADHD Prevalence Estimates Across Three Decades: An Updated Systematic Review and Meta-Regression Analysis
Guilherme V. Polanczyk, MD, PhD University of São Paulo School of Medicine and National Institute of Developmental Psychiatry for Children and Adolescents, São Paulo Brazil
Erik G. Willcutt University of Colorado, Boulder, CO
Giovanni Salum, MD Federal University of Rio Grande do Sul, Porto Alegre Brazil
Christian Kieling, MD Hospital de Clínicas de Porto Alegre, Porto Alegre Brazil
Luis A. Rohde, PhD Federal University of Rio Grande do Sul, Porto Alegre Brazil
 
3.45
Prevalence of ADHD in a Sample of Italian Students: A Population-Based Study
Rio Bianchini, MD Azienda Sanitaria Provinciale di Siracusa, Siracusa Italy
Valentina Postorino, PhD I.R.C.C.S. Children's Hospital Bambino Gesù, Rome Italy
Rita Grasso, MD Azienda Sanitaria Provinciale di Siracusa, Siracusa Italy
Bartolo Santoro, MD Azienda Sanitaria Provinciale di Siracusa, Siracusa Italy
Salvatore Migliore, MD Azienda Sanitaria Provinciale di Siracusa, Siracusa Italy
Corrado Burlo', MD Azienda Sanitaria Provinciale di Siracusa, Siracusa Italy
Carmela Tata, MD Azienda Sanitaria Provinciale di Siracusa, Siracusa Italy
Luigi Mazzone, MD I.R.C.C.S. Children's Hospital Bambino Gesù, Rome Italy
 
3.46
Age 31 Psychiatric Outcomes of Childhood Language Impairment: A 26-Year Prospective, Longitudinal Study
Joseph Beitchman, MD, FRCPC Centre for Addiction and Mental Health and the University of Toronto, Toronto, ON
Elizabeth Brownlie, PhD Centre for Addiction and Mental Health and the University of Toronto, Toronto, ON
Lin Bao, BS Centre for Addiction and Mental Health and the University of Toronto, Toronto, ON
 
3.47
Presenting Mental Health Problems in Pediatric Primary Care: Results from a Large Sample Using the Strengths and Difficulties Questionnaire
Matthew G. Biel, MD, MSC Georgetown University School of Medicine, Washington, DC
Bruno Anthony, PhD Georgetown University Center for Child and Human Development, Washington, DC
Nicole Kahn, MEd Georgetown University Center for Child and Human Development, Washington, DC
Anji Srivastava, MD Georgetown University School of Medicine, Washington, DC
My Banh, PhD Georgetown University School of Medicine, Washington, DC
Lawrence Wissow, MD Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
 
3.48
ADHD Symptoms Predict Response to Working Memory Training
Amber D Hunt, DO Indiana University School of Medicine, Indianapolis, IN
William G. Kronenberger, PhD Indiana University School of Medicine, Indianapolis, IN
David W. Dunn, MD Indiana University School of Medicine, Indianapolis, IN
Bradley S. Gibson, PhD University of Notre Dame, Notre Dame, IN
Dawn M. Gondoli, PhD University of Notre Dame, Notre Dame, IN
 
3.49
How To Approach Teachers to Obtain Information on ADHD Symptoms: Testing Three Different Strategies
Renata Kieling, MD Hospital de Clínicas de Porto Alegre, Porto Alegre Brazil
Christian Kieling, MD Hospital de Clínicas de Porto Alegre, Porto Alegre Brazil
Luis A. Rohde, PhD Federal University of Rio Grande do Sul, Porto Alegre Brazil
 
3.50
Antipsychotic Prescribing Patterns in Child and Adolescent Patients from 2003 to 2010
Kathryn K. Erickson-Ridout, MD, PhD Brown University, Providence, RI
Samuel J. Ridout, MD, PhD Brown University, Providence, RI
Junjia Zhu, PhD Penn State College of Medicine, Hershey, PA
 
3.52
Trends in Antipsychotic Use for Pediatric Patients Between 2003-2010
Samuel J. Ridout, MD, PhD Brown University, Providence, RI
Kathryn K. Erickson-Ridout, MD, PhD Brown University, Providence, RI
Junjia Zhu, PhD Penn State College of Medicine, Hershey, PA
 
3.54
Family Arrangements and Child Psychiatric Disorders Among Puerto Rican Children
Olga Santesteban, MS Columbia University Medical Center, New York, NY
Cristiane S. Duarte, PhD Columbia University Medical Center, New York, NY
Glorisa Canino, PhD University of Puerto Rico, Rio Piedras, PR
Hector R. Bird, MD Columbia University Medical Center, New York, NY
 
3.55
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules in Children with ADHD: A Randomized, Placebo-Controlled, Double-Blind Laboratory School Study
Sharon B. Wigal, PhD Unviersity of California at Irvine, Irvine, CA
Earl Nordbrock, PhD Nordbrock Statistical Consulting, Draper, UT
Ann Catherine Childress, MD Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Scott H. Kollins, PhD Duke University Medical Center, Durham, NC
Laurence Lee Greenhill, MD New York Psychiatric Institute, New York, NY
Annamarie Stehli, MPH Unviersity of California at Irvine, Irvine, CA
Wei-Wei Chang, PhD NuTec, Inc., Boston, MA
Akwete Lex Adjei, PhD Rhodes Pharmaceuticals L.P., Coventry, RI
Robert Kupper, PhD Rhodes Pharmaceuticals L.P., Coventry, RI
 
3.56
Implementing an Evidence-Based Treatment for Youth Diagnosed with Depression in an Outpatient Clinic
German Corso, MD University of Texas Southwestern Medical Center, Dallas, TX
Aleksandra A. Foxwell, PhD University of Texas Southwestern Medical Center, Dallas, TX
Taryn Mayes, MS University of Texas Southwestern Medical Center, Flower Mound, TX
Manish Aligeti, M.D. University of Texas Southwestern, Dallas, TX
Jessica King, BA University of Texas Southwestern Medical Center, Dallas, TX
James D. Norcross, MD University of Texas Southwestern Medical Center, Dallas, TX
Catherine Karni, MD University of Texas Southwestern Medical Center, Dallas, TX
Jodie Trello-Rishel, MD University of Texas Southwestern Medical Center, Dallas, TX
Graham J. Emslie, MD University of Texas Southwestern Medical Center, Dallas, TX
 
3.57
Side Effects from use of One or More Psychiatric Medications in a Population-Based Sample of Children
Robert J. Hilt, MD Seattle Children's Hospital and the University of Washington, Seattle, WA
Monica Chaudhari, MS Axio Research, Seattle, WA
Janice F. Bell, MPH, PhD University of California, Davis, Sacramento, CA
Christine Wolf, MS Axio Research, Seattle, WA
Kent Koprowicz, MS Axio Research, Seattle, WA
Bryan H. King, MD Seattle Children's Hospital and University of Washington, Seattle, WA
 
3.58
An Alternative Approach to Scoring the Multimodal Treatment of ADHD-Swanson, Nolan, and Pelham-IV (MTA-SNAP-IV) to Guide Medication Treatment Titration Towards Symptom Resolution
Daniel J. Wagner University of Calgary, Calgary, AB
Isabelle A. Vallerand, BS University of Calgary, Calgary, AB
John D. McLennan, MD, PhD University of Calgary, Calgary, AB
 
3.59
Outcomes from a Canadian Clinic Using the ADHD Treatment Guidelines of the Texas Children's Medication Algorithm Project
Daniel J. Wagner University of Calgary, Calgary, AB
Isabelle A. Vallerand, BS University of Calgary, Calgary, AB
John D. McLennan, MD, PhD University of Calgary, Calgary, AB

See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.